FDA: Don’t Mix Opioid Addiction Medication With Anti-Anxiety Drugs

prescription bill bottles

The Food and Drug Administration (FDA) issued a new warning this week about mixing medication to treat opioid addiction with anti-anxiety drugs. Both types of drugs slow breathing and brain activity.

Combining opioid addiction medications with anti-anxiety drugs can lead to difficulty breathing, coma or death, the agency said. In addition to anti-anxiety drugs such as Valium and Xanax, other drugs that should not be combined with opioid addiction medication include Ambien and Lunesta for insomnia, muscle relaxers Soma and Zanaflex, and antipsychotic drugs Abilify, Invega, and Saphris, the Associated Press reports.

Buprenorphine and methadone, also known as medication-assisted treatment, reduce opioid cravings and withdrawal without producing a high. The FDA is requiring changes to medication-assisted treatment drug labels. The new labels recommend that health care providers develop a treatment plan that closely monitors any simultaneous use of these drugs.

Heroin, Fentanyl & Other Opioids: From Understanding to Action

Heroin and other opioids are ravaging communities across America. Deaths from heroin increased 328% between 2010 and 2015, and drug deaths from fentanyl and other synthetic opioids are now seeing a sharp rise as well. More Americans die from drug overdoses than in car crashes, and this increasing trend is driven by Rx painkillers.